X4 Pharmaceuticals Inc.

X4 Pharmaceuticals Inc. annual/quarterly net income history and growth rate from 2018 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.

• X4 Pharmaceuticals Inc. net income for the quarter ending March 31, 2026 was -20.2 M, a 7277.66% decrease year-over-year.
• X4 Pharmaceuticals Inc. net income for the twelve months ending March 31, 2026 was -75.5 M, a 114516.67% decrease year-over-year.
• X4 Pharmaceuticals Inc. annual net income for 2025 was -79.2 M, a 111.48% increase from 2024.
• X4 Pharmaceuticals Inc. annual net income for 2024 was -37.5 M, a 62.98% decrease from 2023.
• X4 Pharmaceuticals Inc. annual net income for 2023 was -101.2 M, a 7.78% increase from 2022.
• X4 Pharmaceuticals Inc. annual net income for 2022 was -93.9 M.